Leading researchers in California have confirmed that surging cases of a once-rare form of facial paralysis known as oculomotor nerve palsy have been caused by Covid mRNA shots.
Led by Adventist Health neurologist Antonio K. Liu, M.D. and Ifeanyichukwu Ozobu, M.D., the team of researchers at White Memorial Hospital in Los Angeles sought to identify the trigger behind soaring reports of oculomotor nerve palsy, also known as third nerve palsy.
The team is made up of physician investigators from Adventist Health, a faith-based, nonprofit, integrated health system serving more than 90 communities on the West Coast and Hawaii with over 400 sites of care.
Oculomotor nerve palsy is derived from damage to the third cranial nerve.
The condition causes characteristic symptoms, such as a drooping eyelid, double vision, pupil dilation, and deficits in adduction and vertical gaze.
The team of researchers analyzed recent cases of isolated oculomotor nerve palsy and looked into the Covid mRNA-vaccination history of each patient.
Such reported cases can be divided into two groups based on symptom onset: immediate and delayed.
In some cases, oculomotor nerve palsy could emerge shortly after receiving a Covid shot.
Cases of oculomotor nerve palsy associated with the Pfizer and Moderna vaccines occurred within the first few days of vaccination.
However, in other cases, it could emerge weeks after the injection.
As part of the study, the researcher presented a unique case of a patient experiencing isolated, unilateral oculomotor nerve palsy 14 days after receiving the Moderna (mRNA-1273/Spikevax) vaccine.
The case dovetails with a previously reported 17-day onset case and shares the interesting finding of positive ganglioside antibodies – autoantibodies that can be produced against gangliosides, which are glycosphingolipids that contain sialic acid.
The authors warn that their findings “highlight the potential for unusual occurrences following COVID-19 vaccination but also opens up avenues for exploring the underlying mechanisms behind these events.”
The authors do this under the employ of a major health system, evidencing a growing interest in critically vetting the Covid mRNA injections.
The case used by the researchers was reported in the prestigious peer-reviewed journal Cureus.
An 81-year-old male was presented to the emergency department with two days of diplopia also known as double vision.
The patient had no prior confirmed COVID-19 infection.
The facial paralysis manifested after the patient received a Moderna SARS-CoV-2 mRNA booster vaccination 16 days before the onset of the condition.
The onset of symptoms occurred 14 days after the vaccination.
During the day of the vaccine administration, the patient reported only mild malaise, and importantly, all “past medical history, family history, and social history were all non-contributory.”
The physicians performed their examination while documenting the case.
The doctors reported finding “His pupils were both reactive to light.
“On digital pupillometry, his pupils showed slightly different sizes (right: 3.22 mm, left: 3.45 mm) and demonstrated decreased reactivity in the right eye (Neurological Pupillary Index: right 2.2, left 2.7).”
The doctors conclude that such “findings were consistent with an isolated right oculomotor nerve palsy that spared the pupil.”
The patient refused a lumbar puncture but various blood tests were performed to check for myasthenia gravis, autoimmune neurological diseases, and ganglioside antibodies.
By the third day in the hospital, the patient’s condition improved without needing any immunosuppressive medications.
Thereafter, he was discharged home shortly after.
Subsequently, the only antibody that came back positive was serum Asialo-GM1 antibodies, IgG/IgM 70 IV (0-50).
A follow-up appointment 14 days after discharge confirmed the complete resolution of all his symptoms.
The authors found seven case reports describing confirmed isolated oculomotor nerve palsy, plus a few case series.
But applying exclusion criteria, only two case series remained relevant.
“One series reported a single additional case of oculomotor nerve palsy” with the other including another nine cases, however, specific details on clinical features were lacking.
According to the physicians, this was “making it impossible to confirm if these truly represented isolated oculomotor palsy.”
In total, the Adventist Health investigators report on investigating nine total cases of confirmed isolated oculomotor nerve palsy.
“Three of the cases had received the Moderna vaccine while six had received the Pfizer vaccination.”
Six of the patients experienced the condition within one to six days post-vaccination (three on day one, two on day three, and one on day six).
Another three patients developed symptoms later, at days 12, 14 (our case), and 17 (two with Moderna and one with Pfizer).
The researchers identified two mechanisms as possible explanations for this Covid mRNA injection response:
| Observation | Potential Mechanism |
| Direct damage to the nerve due to an immune response triggered directly by the vaccine | This mechanism might involve interferons, similar to what has been observed in interferon-mediated Bell’s palsy after COVID-19 vaccination |
| Indirect immune-mediated injury to the nerve | The body’s inflammatory response to the vaccine triggers an attack on the nerve, potentially leading to demyelination or reduced blood flow and ultimately oculomotor nerve palsy |
The authors suggest that based on their expertise and literature reviews on the class of injury associated with delayed-onset cases like the current patient, “molecular mimicry might be the underlying mechanism.
“This autoimmune mechanism involves the immune system mistaking the body’s tissues for a foreign invader.
“Autoimmune neurological conditions like GBS and MFS share this delayed presentation and underlying mechanism.”
“Interestingly, of the nine cases analyzed, the two patients with delayed presentations (after 12 and 17 days) who received plasma exchange therapy (a type of immunosuppressive therapy used to rapidly remove autoantibodies) recovered successfully.”
Patients who suffered from this once-rare condition “whose symptoms presented after 17 days had positive anti-GQ1B antibodies, a marker of autoimmunity,” the study found
Applying to the present case the Adventist Health doctors point out their patient’s “positive Asialo-GM1 antibodies, another marker of autoimmunity, along with the delayed presentation, suggest an autoimmune etiology.
“However, the rapid improvement our patient experienced indicated that immunosuppressive therapy was not necessary.
“Overall, these findings suggest that the cause of the oculomotor nerve palsy presentation after COVID-19 vaccination, especially in the delayed-onset group, may have an autoimmune origin.”
Meanwhile, a separate major new study of 2.7 billion people has determined that COVID-19 did not cause any excess deaths during or after the pandemic, despite widespread claims to the contrary from health agencies around the world, as Slay News reported.
However, the same explosive study has revealed that Covid mRNA shots, which were supposedly unleashed on the public to tackle the virus, have caused millions of excess deaths globally.
The study found that the excess all-cause mortality in 125 countries is incompatible with a pandemic viral respiratory disease.
The researchers analyzed excess mortality across the world during the pandemic years of 2020 to 2023.
They calculated that, by December 2022, the Covid mRNA injections had killed 16.9 million people.
No comments:
Post a Comment